Add-on Acquisition • Medical Products

NatImmune A/S Acquires HAMLET Pharma AB

On September 7, 2006, NatImmune A/S acquired medical products company HAMLET Pharma AB

Acquisition Context

This is NatImmune A/S’s 1st transaction in the Medical Products sector.
This is NatImmune A/S’s 1st transaction in Sweden.

Explore All 2734 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	September 7, 2006
Target	HAMLET Pharma AB
Sector	Medical Products
Buyer(s)	NatImmune A/S
Deal Type	Add-on Acquisition

Target Company

HAMLET Pharma AB

Lund, Sweden

HAMLET Pharma AB is a researcher and developer of cancer therapeutics based on Human Alpha-lactalbumin Made LEthal to Tumours (HAMLET).

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Buyer Overview 1

Buyer

NatImmune A/S

Copenhagen, Denmark

Category	Company
Founded	2000
Sector	Medical Products

DESCRIPTION

NatImmune A/S is a biotechnology company focuses on the development of protein-based therapeutics.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Medical Products	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Sweden	1 of 1
Year: 2006	1 of 1

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - Sweden M&A - 2006 M&A